Which Assay for Atezolizumab?
12/08/2019 | Emina Torlakovic, Allen M. Gown
Emina Torlakovic and Allen Gown share their disagreements with David Rimm’s comments about an FDA-approved PD-L1 assay for atezolizumab
Cancer Trap
12/10/2019 | Luke Turner
New synthetic scaffolds that sit under the skin and attract cancer cells could provide the earliest indication of metastasis
Tweet of the week

What exactly is the fine art of grossing? How much do you know about the AAPA’s Grossing Guidelines? Cory Nash and Jesse McCoy have all the answers – and they want to hear from you.

The Future of Digital Pathology

Did you miss the panel discussion at the recent Digital Pathology and AI Congress in London? Fear not! Find out what the experts had to say on the future of the field from our live Twitter thread.

Register to The Pathologist now and unlock all areas. It's free and includes:
  • In-depth features covering the most pressing issues in pathology
  • Opinion and commentary from experts across the globe
  • One-to-one interviews with the biggest names in the field
  • and much, much more...
Register now
Product Profiles
Atellica® Diagnostics IT – Less work. More Flow.

Atellica® Diagnostics IT leverages data-driven innovation to simplify workflows. Read more

Horizon launch new MSI FFPE DNA reference standard

This new MSI FFPE DNA Reference Standard contains 20 biomarkers relevant to microsatellite instability (MSI) status. Ideal for the validation of new and existing MSI workflows. Read More.

Special Promotion
Discover the ddPCR Power Advantage

Learn about the first and only FDA-cleared ddPCR kit for BCR-ABL testing. See how a promising new technology can help.

Upcoming Events

Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the laboratory medicine industry – so why not take a look at our list of upcoming events?

More information